- Home
- CRVO vs DTF Comparison
CRVO vs DTF Comparison
Compare CRVO & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRVO | DTF |
|---|---|---|
| Founded | 2001 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.1M | 79.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRVO | DTF |
|---|---|---|
| Price | $8.80 | $11.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $21.50 | N/A |
| AVG Volume (30 Days) | ★ 86.5K | 21.1K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.64% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | ★ $6,159,786.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.34 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.80 | $10.29 |
| 52 Week High | $16.94 | $11.19 |
Technical Indicators
Market Signals| Indicator | CRVO | DTF |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 55.06 |
| Support Level | $7.80 | $11.27 |
| Resistance Level | $10.00 | $11.40 |
| Average True Range (ATR) | 0.75 | 0.05 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 47.39 | 85.71 |
Price Performance
Historical ComparisonAbout CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.